NCT06119308View on ClinicalTrials.gov

Brief Cognitive Behavioral Therapy to Enhance Benzodiazepine Deprescribing

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 8, 2023

Primary Completion Date

October 30, 2024

Study Completion Date

June 30, 2025

Conditions
Benzodiazepine UseInsomniaAnxiety
Interventions
OTHER

Benzodiazepine Medication Taper with Cognitive Behavioral Therapy

Brief Cognitive Behavioral Therapy to Enhance Benzodiazepine Deprescribing (led by pharmacist/clinician/psychologist) over a 10-week Trial.

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

collaborator

University of Pittsburgh

OTHER

lead

Beth Israel Deaconess Medical Center

OTHER

NCT06119308 - Brief Cognitive Behavioral Therapy to Enhance Benzodiazepine Deprescribing | Biotech Hunter | Biotech Hunter